Assured Investment Management’s Integra LifeSciences IART Stock Holding History

Assured Investment Management’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-52,783	Closed	-$2.94M	–	410
2019 Q1	$2.94M	Buy	+52,783	New	+$2.69M	0.03%	231
2017 Q2	–	Sell	-30,953	Closed	-$1.3M	–	649
2017 Q1	$1.3M	Buy	+30,953	New	+$1.32M	0.03%	242
2016 Q4	–	Sell	-7,900	Closed	-$326K	–	639
2016 Q3	$326K	Buy	+7,900	New	+$331K	0.01%	472

Other funds holding IART

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Assured Investment Management's IART Position: Q2 2019 in Review

Assured Investment Management sold out of Integra LifeSciences (IART) in Q2 2019, closing a stake of 52,783 shares — an estimated $2.94M sold.

Assured Investment Management first reported a position in IART in Q3 2016 and held it in 3 quarters. The position peaked at $2.94M in Q1 2019. 262 funds tracked by Wall St. Rank hold IART as of Q2 2019.

Assured Investment Management reported no remaining Integra LifeSciences position as of Q2 2019 after selling out during the quarter.
Assured Investment Management sold 52,783 Integra LifeSciences shares in Q2 2019, an estimated $2.94M.
Assured Investment Management first reported a position in Integra LifeSciences in Q3 2016 and held it in 3 quarters.
Assured Investment Management's Integra LifeSciences position peaked at $2.94M in Q1 2019.
262 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2019.

Based on Assured Investment Management's 13F filing for Q2 2019, filed 14 Aug 2019.